UPDATE 2-FDA panel unanimously backs expanding use of Amarin's heart drug Vascepa
November 14, 2019 at 17:58 PM EST
A panel of experts to the U.S. FDA recommended allowing Amarin Corp Plc's fish-oil derived drug to be used as an add-on therapy for reducing the chance of heart attacks and strokes in high-risk patients with cardiovascular disease.